These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 8524243

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Inhibition of a signaling pathway in cardiac muscle cells by active mitogen-activated protein kinase kinase.
    Thorburn J, Carlson M, Mansour SJ, Chien KR, Ahn NG, Thorburn A.
    Mol Biol Cell; 1995 Nov; 6(11):1479-90. PubMed ID: 8589450
    [Abstract] [Full Text] [Related]

  • 23. The c-Jun delta-domain inhibits neuroendocrine promoter activity in a DNA sequence- and pituitary-specific manner.
    Farrow KN, Manning N, Schaufele F, Gutierrez-Hartmann A.
    J Biol Chem; 1996 Jul 19; 271(29):17139-46. PubMed ID: 8663380
    [Abstract] [Full Text] [Related]

  • 24. Transcriptional regulation of the TATA-binding protein by Ras cellular signaling.
    Johnson SA, Mandavia N, Wang HD, Johnson DL.
    Mol Cell Biol; 2000 Jul 19; 20(14):5000-9. PubMed ID: 10866657
    [Abstract] [Full Text] [Related]

  • 25. Regulation of the PRL promoter by Akt through cAMP response element binding protein.
    Hayakawa J, Ohmichi M, Tasaka K, Kanda Y, Adachi K, Nishio Y, Hisamoto K, Mabuchi S, Hinuma S, Murata Y.
    Endocrinology; 2002 Jan 19; 143(1):13-22. PubMed ID: 11751586
    [Abstract] [Full Text] [Related]

  • 26. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway.
    Geppert TD, Whitehurst CE, Thompson P, Beutler B.
    Mol Med; 1994 Nov 19; 1(1):93-103. PubMed ID: 8790605
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Involvement of a mitogen-activated protein kinase signaling pathway in the regulation of urokinase promoter activity by c-Ha-ras.
    Lengyel E, Stepp E, Gum R, Boyd D.
    J Biol Chem; 1995 Sep 29; 270(39):23007-12. PubMed ID: 7559439
    [Abstract] [Full Text] [Related]

  • 29. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation.
    Khosravi-Far R, White MA, Westwick JK, Solski PA, Chrzanowska-Wodnicka M, Van Aelst L, Wigler MH, Der CJ.
    Mol Cell Biol; 1996 Jul 29; 16(7):3923-33. PubMed ID: 8668210
    [Abstract] [Full Text] [Related]

  • 30. Fibroblast growth factors regulate prolactin transcription via an atypical Rac-dependent signaling pathway.
    Jackson TA, Koterwas DM, Morgan MA, Bradford AP.
    Mol Endocrinol; 2003 Oct 29; 17(10):1921-30. PubMed ID: 12843210
    [Abstract] [Full Text] [Related]

  • 31. Inhibitory actions of cyclic adenosine monophosphate and pertussis toxin define two distinct epidermal growth factor-regulated pathways leading to activation of mitogen-activated protein kinase in rat hepatocytes.
    Ginès P, Li X, Brown SE, Nakamura T, Guzelian PS, Heasley LE, Schrier RW, Nemenoff RA.
    Hepatology; 1996 May 29; 23(5):1167-73. PubMed ID: 8621150
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Lipopolysaccharide and Raf-1 kinase regulate secretory interleukin-1 receptor antagonist gene expression by mutually antagonistic mechanisms.
    Guthridge CJ, Eidlen D, Arend WP, Gutierrez-Hartmann A, Smith MF.
    Mol Cell Biol; 1997 Mar 29; 17(3):1118-28. PubMed ID: 9032239
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A role for the mitogen-activated protein kinase in mediating the ability of thyrotropin-releasing hormone to stimulate the prolactin promoter.
    Wang YH, Maurer RA.
    Mol Endocrinol; 1999 Jul 29; 13(7):1094-104. PubMed ID: 10406461
    [Abstract] [Full Text] [Related]

  • 36. A Pit-1 threonine 220 phosphomimic reduces binding to monomeric DNA sites to inhibit Ras and estrogen stimulation of the prolactin gene promoter.
    Jean A, Gutierrez-Hartmann A, Duval DL.
    Mol Endocrinol; 2010 Jan 29; 24(1):91-103. PubMed ID: 19887646
    [Abstract] [Full Text] [Related]

  • 37. Integrin-mediated activation of MEK and mitogen-activated protein kinase is independent of Ras [corrected].
    Chen Q, Lin TH, Der CJ, Juliano RL.
    J Biol Chem; 1996 Jul 26; 271(30):18122-7. PubMed ID: 8663436
    [Abstract] [Full Text] [Related]

  • 38. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades.
    O'Hagan RC, Tozer RG, Symons M, McCormick F, Hassell JA.
    Oncogene; 1996 Sep 19; 13(6):1323-33. PubMed ID: 8808707
    [Abstract] [Full Text] [Related]

  • 39. Transforming growth factor-beta1 inhibits rat prolactin promoter activity in GH4 neuroendocrine cells.
    Farrow KN, Gutierrez-Hartmann A.
    DNA Cell Biol; 1999 Nov 19; 18(11):863-73. PubMed ID: 10595400
    [Abstract] [Full Text] [Related]

  • 40. The Pit-1 homeodomain and beta-domain interact with Ets-1 and modulate synergistic activation of the rat prolactin promoter.
    Bradford AP, Brodsky KS, Diamond SE, Kuhn LC, Liu Y, Gutierrez-Hartmann A.
    J Biol Chem; 2000 Feb 04; 275(5):3100-6. PubMed ID: 10652292
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.